IREN

IREN Limited

There isn't enough reported data to score IREN yet.

PAX

Patria Investments Limited

43
Fundamentals38/ 100
Valuation53/ 100
Upside potential57/ 100
Risk potential16/ 100

PAX's fundamentals are weak: its operating margin fell 13 points to 29% and earnings per share fell 18%, though revenue grew 8.3%. At 20x earnings, it's trading below its usual 23x. Analysts expect earnings to hold roughly steady.

IREN Fundamentals

MetricStatus
Under pressure
Weak
N/A
N/A

IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.

PAX Fundamentals

MetricStatus
Healthy
Healthy
N/A
N/A

PAX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PAX.

IREN PE Valuation

IREN has no meaningful PE right now: it lost money over the past year.

PAX PE Valuation

CHEAPFAIREXPENSIVE13x25x38x50x
CHEAPFAIREXPENSIVE13x25x38x50x
LevelPEPriceVs current
Forward6.9x$9.18—
Cheap17x$7.80-15%
Current20x$9.18—
Fair23x$10.23+11%
Expensive29x$12.85+40%

Historical ranges are pointers, not guarantees.

PAX's PE is in its fair range at 20x. On analysts' estimates for next year's earnings, today's price would be 6.9x, in its cheap range.

IREN Forward outlook

MetricOutlook
--
Losses growing
Strong growth
Strongly improving
Limited
Low

Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.

PAX Forward outlook

MetricOutlook
Strongly improving
Stable
Growth
Strongly weakening
Limited
Moderate

Analysts expect PAX's revenue to grow, but its profitability to weaken.

IREN Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $19.48 on Nov 12.

There is not enough scenario data to compare IREN and PAX's risk to reward.

PAX Risk to reward

ScenarioChangePrice
Upside+22%$11.18
Downside-16%$7.68

Calculated from the latest close: $9.18 on Nov 12.

There is not enough scenario data to compare IREN and PAX's risk to reward.

IREN Earnings Per Share

Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
QuarterTTM EPSYoY
Q3 2026-$3.96-347%
Q2 2026-$2.22-988%
Q1 2026$0.51+$1.10
Q4 2025$1.18+$1.62
Q3 2025$1.60+$1.99
Q2 2025$0.25+$0.45
Q1 2025-$0.59-$0.43
Q4 2024-$0.44-$0.15

IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.

PAX Earnings Per Share

Q3 2023: $0.80Q4 2023: $0.79Q1 2024: $0.77Q2 2024: $0.54Q3 2024: $0.43Q4 2024: $0.49Q1 2025: $0.47Q2 2025: $0.55Q3 2025: $0.69Q4 2025: $0.54Q1 2026: $0.47Q2 2026: $0.45Forward: $1.33
Q3 2023: $0.80Q4 2023: $0.79Q1 2024: $0.77Q2 2024: $0.54Q3 2024: $0.43Q4 2024: $0.49Q1 2025: $0.47Q2 2025: $0.55Q3 2025: $0.69Q4 2025: $0.54Q1 2026: $0.47Q2 2026: $0.45Forward: $1.33
QuarterTTM EPSYoY
Forward$1.33+196%
Q2 2026$0.45-18%
Q1 2026$0.470%
Q4 2025$0.54+10%
Q3 2025$0.69+60%
Q2 2025$0.55+1.9%
Q1 2025$0.47-39%
Q4 2024$0.49-38%
Q3 2024$0.43-46%

PAX has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.

IREN Quarterly Revenue

Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
QuarterRevenueYoY
Q3 2026$228M-5.1%
Q2 2026$137.2M-27%
Q1 2026$144.8M0%
Q4 2025$184.7M+59%
Q3 2025$240.3M+355%
Q2 2025$187.3M+230%
Q1 2025$144.8M+168%
Q4 2024$116.1M+176%

IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.

PAX Quarterly Revenue

Q3 2023: $64MQ4 2023: $112MQ1 2024: $64MQ2 2024: $75MQ3 2024: $78MQ4 2024: $157MQ1 2025: $80MQ2 2025: $83MQ3 2025: $86MQ4 2025: $134MQ1 2026: $98MQ2 2026: $111M
Q3 2023: $64MQ4 2023: $112MQ1 2024: $64MQ2 2024: $75MQ3 2024: $78MQ4 2024: $157MQ1 2025: $80MQ2 2025: $83MQ3 2025: $86MQ4 2025: $134MQ1 2026: $98MQ2 2026: $111M
QuarterRevenueYoY
Q2 2026$111.3M+35%
Q1 2026$98.2M+23%
Q4 2025$134.4M-15%
Q3 2025$86.5M+11%
Q2 2025$82.5M+10%
Q1 2025$79.6M+25%
Q4 2024$157.2M+41%
Q3 2024$78.1M+23%

PAX's revenue is recovering but still below its 2024 peak: $111M last quarter, up 35% from the same quarter a year ago.

IREN Free Cash Flow

Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
QuarterFree cash flowYoY
Q3 2026-$1.6B-$1.6B
Q2 2026$482.2M+2895%
Q1 2026-$873.8M-$523.1M
Q4 2025-$468M-$334M
Q3 2025-$38M+$349.4M
Q2 2025$16.1M+$179M
Q1 2025-$350.7M-$128.7M
Q4 2024-$134M-$105.2M

IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.

PAX Free Cash Flow

Q3 2023: $38MQ4 2023: $33MQ1 2024: $40MQ2 2024: $7MQ3 2024: $67MQ4 2024: $23MQ1 2025: $98MQ2 2025: $73MQ3 2025: $52MQ4 2025: $32MQ1 2026: $28MQ2 2026: $36M
Q3 2023: $38MQ4 2023: $33MQ1 2024: $40MQ2 2024: $7MQ3 2024: $67MQ4 2024: $23MQ1 2025: $98MQ2 2025: $73MQ3 2025: $52MQ4 2025: $32MQ1 2026: $28MQ2 2026: $36M
QuarterFree cash flowYoY
Q2 2026$35.5M-51%
Q1 2026$28.4M-71%
Q4 2025$32.3M+40%
Q3 2025$52.1M-22%
Q2 2025$72.9M+879%
Q1 2025$97.8M+144%
Q4 2024$23.1M-29%
Q3 2024$67M+75%

PAX has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.

IREN Total Shares

Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
PeriodChange %Net change
Quarterly+26%+82.4M shares
1 year+10%+36.9M shares
3 years+511%+333M shares
5 years+624%+344M shares
Available history+2346%+382M shares

IREN has 399M diluted shares, up 10% from a year ago.

PAX Total Shares

Q3 2023: 148MQ4 2023: 149MQ1 2024: 152MQ2 2024: 152MQ3 2024: 153MQ4 2024: 154MQ1 2025: 158MQ2 2025: 158MQ3 2025: 153MQ4 2025: 158MQ1 2026: 159MQ2 2026: 160M
Q3 2023: 148MQ4 2023: 149MQ1 2024: 152MQ2 2024: 152MQ3 2024: 153MQ4 2024: 154MQ1 2025: 158MQ2 2025: 158MQ3 2025: 153MQ4 2025: 158MQ1 2026: 159MQ2 2026: 160M
PeriodChange %Net change
Quarterly+0.6%+953K shares
1 year+0.9%+1.5M shares
3 years+7.7%+11.4M shares
5 years+19%+25.6M shares
Available history+36%+42.6M shares

PAX has the edge over IREN on shareholder dilution, with a more favorable share count trend.

IREN Net Leverage

Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
QuarterNet LeverageStatus
Q1 2026157.6xHigh
Q4 202522.2xHigh
Q3 20254.1xHigh
Q2 20252.0xModerate
Q1 20253.3xElevated
Q4 2024-4.6xNet Cash
Q3 2024-16.7xNet Cash
Q2 2024-15.9xNet Cash

IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.

PAX Net Leverage

Q3 2023: -0.0xQ4 2023: -0.0xQ1 2024: 0.5xQ2 2024: 1.2xQ3 2024: 1.1xQ4 2024: 1.5xQ1 2025: 1.3xQ2 2025: 1.0xQ3 2025: 0.8xQ4 2025: 0.9xQ1 2026: 1.3xQ2 2026: 2.2x
Q3 2023: -0.0xQ4 2023: -0.0xQ1 2024: 0.5xQ2 2024: 1.2xQ3 2024: 1.1xQ4 2024: 1.5xQ1 2025: 1.3xQ2 2025: 1.0xQ3 2025: 0.8xQ4 2025: 0.9xQ1 2026: 1.3xQ2 2026: 2.2x
QuarterNet LeverageStatus
Q2 20262.2xModerate
Q1 20261.3xHealthy
Q4 20250.9xVery low
Q3 20250.8xVery low
Q2 20251.0xHealthy
Q1 20251.3xHealthy
Q4 20241.5xHealthy
Q3 20241.1xHealthy

PAX has the edge over IREN on leverage, with a lower net debt burden relative to earnings.

IREN Weekly Momentum

MetricValueStatus
RSI33.3Neutral
Stochastic8.2Oversold

IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).

PAX Weekly Momentum

MetricValueStatus
RSI35.2Neutral
Stochastic8.1Oversold

PAX's weekly RSI is 35 (neutral) and its Stochastic is 8 (oversold).

IREN PE vs Financial Services Sector

MetricIRENSector medianRelative
PEN/A13x—

IREN has no meaningful PE right now: it lost money over the past year.

PAX PE vs Financial Services Sector

MetricPAXSector medianRelative
PE20x13x57% above
PE %406222 pts below

PAX is trading at 20x earnings, a 57% premium to the Financial Services sector's median of 13x.

IREN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.835% below
20 week MA$36.246% below
50 week MA$42.854% below
100 week MA$32.039% below
200 week MA$19.12.1% above

IREN has the edge over PAX on trend strength, trading above more of its moving averages.

PAX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.412% below
20 week MA$10.815% below
50 week MA$12.426% below
100 week MA$12.627% below
200 week MA$13.231% below

PAX is in a downtrend: it's below all five of its weekly moving averages, and 31% below its 200-week average.

IREN Yearly ROI

YearStart priceEnd priceROI
2021$24.8$17.2-31%
2022$17.2$1.19-93%
2023$1.19$7.15+501%
2024$7.15$10.7+50%
2025$10.7$40.3+276%
2026 YTD$40.3$19.5-52%

IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.

PAX Yearly ROI

YearStart priceEnd priceROI
2021$19.9$16.5-17%
2022$16.5$13.7-17%
2023$13.7$15.5+13%
2024$15.5$11.6-25%
2025$11.6$16.2+39%
2026 YTD$16.2$9.18-43%

PAX has the edge over IREN on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key